Effects of MDMA on the Human Nervous System

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

(±)3,4-Methylenedioxymethamphetamine (MDMA, Ecstasy) is a synthetic ring-substituted amphetamine analog that produces a unique blend of stimulant and psychedelic effects. Considerable research demonstrates that MDMA has the potential to damage brain serotonin (5-HT)-containing neurons in animals, and a growing body of data indicates that MDMA is also a 5-HT neurotoxin in humans. This chapter begins with a review of the history of MDMA's origins and early use practices, its emergence as a "party drug" in the 1990s, and its more recent reemergence as a potential psychotherapeutic adjunct in insight-oriented therapy. The major focus of this chapter addresses MDMA's effects on the human nervous system. To this end, MDMA's mechanism of action and its effects on the sympathetic nervous system are first detailed. The ensuing discussion addresses MDMA's effects on the central nervous system, including its pharmacological and neurotoxic effects, relying on information from preclinical models, when appropriate. Studies in humans that have attempted to identify lasting functional consequences of MDMA-induced 5-HT injury on cognitive function, sleep, neuroendocrine control, and pain function are reviewed, and evidence that MDMA may precipitate acute or lasting neuropsychiatric disorders is discussed. Finally, limitations of existing data in humans are discussed, and suggested directions for future research are provided.

Original languageEnglish (US)
Title of host publicationThe Effects of Drug Abuse on the Human Nervous System
PublisherElsevier Inc.
Pages475-497
Number of pages23
ISBN (Print)9780124186798
DOIs
StatePublished - Dec 2013

Fingerprint

N-Methyl-3,4-methylenedioxyamphetamine
Nervous System
Serotonin
Hallucinogens
Sympathetic Nervous System
Neurotoxins
Amphetamine
Cognition
Sleep
Central Nervous System
History
Pharmacology
Neurons

Keywords

  • Dopamine
  • MDMA
  • Monoamine Transporters
  • Norepinephrine
  • Psychiatric Disorders
  • Serotonin
  • Sleep

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

McCann, U. D., & Ricaurte, G. (2013). Effects of MDMA on the Human Nervous System. In The Effects of Drug Abuse on the Human Nervous System (pp. 475-497). Elsevier Inc.. https://doi.org/10.1016/B978-0-12-418679-8.00015-0

Effects of MDMA on the Human Nervous System. / McCann, Una D; Ricaurte, George.

The Effects of Drug Abuse on the Human Nervous System. Elsevier Inc., 2013. p. 475-497.

Research output: Chapter in Book/Report/Conference proceedingChapter

McCann, UD & Ricaurte, G 2013, Effects of MDMA on the Human Nervous System. in The Effects of Drug Abuse on the Human Nervous System. Elsevier Inc., pp. 475-497. https://doi.org/10.1016/B978-0-12-418679-8.00015-0
McCann UD, Ricaurte G. Effects of MDMA on the Human Nervous System. In The Effects of Drug Abuse on the Human Nervous System. Elsevier Inc. 2013. p. 475-497 https://doi.org/10.1016/B978-0-12-418679-8.00015-0
McCann, Una D ; Ricaurte, George. / Effects of MDMA on the Human Nervous System. The Effects of Drug Abuse on the Human Nervous System. Elsevier Inc., 2013. pp. 475-497
@inbook{e43bdfe6b71a446693dc399af231baef,
title = "Effects of MDMA on the Human Nervous System",
abstract = "(±)3,4-Methylenedioxymethamphetamine (MDMA, Ecstasy) is a synthetic ring-substituted amphetamine analog that produces a unique blend of stimulant and psychedelic effects. Considerable research demonstrates that MDMA has the potential to damage brain serotonin (5-HT)-containing neurons in animals, and a growing body of data indicates that MDMA is also a 5-HT neurotoxin in humans. This chapter begins with a review of the history of MDMA's origins and early use practices, its emergence as a {"}party drug{"} in the 1990s, and its more recent reemergence as a potential psychotherapeutic adjunct in insight-oriented therapy. The major focus of this chapter addresses MDMA's effects on the human nervous system. To this end, MDMA's mechanism of action and its effects on the sympathetic nervous system are first detailed. The ensuing discussion addresses MDMA's effects on the central nervous system, including its pharmacological and neurotoxic effects, relying on information from preclinical models, when appropriate. Studies in humans that have attempted to identify lasting functional consequences of MDMA-induced 5-HT injury on cognitive function, sleep, neuroendocrine control, and pain function are reviewed, and evidence that MDMA may precipitate acute or lasting neuropsychiatric disorders is discussed. Finally, limitations of existing data in humans are discussed, and suggested directions for future research are provided.",
keywords = "Dopamine, MDMA, Monoamine Transporters, Norepinephrine, Psychiatric Disorders, Serotonin, Sleep",
author = "McCann, {Una D} and George Ricaurte",
year = "2013",
month = "12",
doi = "10.1016/B978-0-12-418679-8.00015-0",
language = "English (US)",
isbn = "9780124186798",
pages = "475--497",
booktitle = "The Effects of Drug Abuse on the Human Nervous System",
publisher = "Elsevier Inc.",

}

TY - CHAP

T1 - Effects of MDMA on the Human Nervous System

AU - McCann, Una D

AU - Ricaurte, George

PY - 2013/12

Y1 - 2013/12

N2 - (±)3,4-Methylenedioxymethamphetamine (MDMA, Ecstasy) is a synthetic ring-substituted amphetamine analog that produces a unique blend of stimulant and psychedelic effects. Considerable research demonstrates that MDMA has the potential to damage brain serotonin (5-HT)-containing neurons in animals, and a growing body of data indicates that MDMA is also a 5-HT neurotoxin in humans. This chapter begins with a review of the history of MDMA's origins and early use practices, its emergence as a "party drug" in the 1990s, and its more recent reemergence as a potential psychotherapeutic adjunct in insight-oriented therapy. The major focus of this chapter addresses MDMA's effects on the human nervous system. To this end, MDMA's mechanism of action and its effects on the sympathetic nervous system are first detailed. The ensuing discussion addresses MDMA's effects on the central nervous system, including its pharmacological and neurotoxic effects, relying on information from preclinical models, when appropriate. Studies in humans that have attempted to identify lasting functional consequences of MDMA-induced 5-HT injury on cognitive function, sleep, neuroendocrine control, and pain function are reviewed, and evidence that MDMA may precipitate acute or lasting neuropsychiatric disorders is discussed. Finally, limitations of existing data in humans are discussed, and suggested directions for future research are provided.

AB - (±)3,4-Methylenedioxymethamphetamine (MDMA, Ecstasy) is a synthetic ring-substituted amphetamine analog that produces a unique blend of stimulant and psychedelic effects. Considerable research demonstrates that MDMA has the potential to damage brain serotonin (5-HT)-containing neurons in animals, and a growing body of data indicates that MDMA is also a 5-HT neurotoxin in humans. This chapter begins with a review of the history of MDMA's origins and early use practices, its emergence as a "party drug" in the 1990s, and its more recent reemergence as a potential psychotherapeutic adjunct in insight-oriented therapy. The major focus of this chapter addresses MDMA's effects on the human nervous system. To this end, MDMA's mechanism of action and its effects on the sympathetic nervous system are first detailed. The ensuing discussion addresses MDMA's effects on the central nervous system, including its pharmacological and neurotoxic effects, relying on information from preclinical models, when appropriate. Studies in humans that have attempted to identify lasting functional consequences of MDMA-induced 5-HT injury on cognitive function, sleep, neuroendocrine control, and pain function are reviewed, and evidence that MDMA may precipitate acute or lasting neuropsychiatric disorders is discussed. Finally, limitations of existing data in humans are discussed, and suggested directions for future research are provided.

KW - Dopamine

KW - MDMA

KW - Monoamine Transporters

KW - Norepinephrine

KW - Psychiatric Disorders

KW - Serotonin

KW - Sleep

UR - http://www.scopus.com/inward/record.url?scp=84903343708&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84903343708&partnerID=8YFLogxK

U2 - 10.1016/B978-0-12-418679-8.00015-0

DO - 10.1016/B978-0-12-418679-8.00015-0

M3 - Chapter

AN - SCOPUS:84903343708

SN - 9780124186798

SP - 475

EP - 497

BT - The Effects of Drug Abuse on the Human Nervous System

PB - Elsevier Inc.

ER -